News-Papers
Testimonial
Video Gallery
Search
Follow us...
Latest
- Somatostatin receptor subtype 1-selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line
- Vitamin D supplementation and survival of patients with non-small-cell lung cancer: A randomized, double-blind, placebo-controlled trial
- New somatostatin-drug conjugates for effective targeting pancreatic cancer
- Melatonin restrains angiogenic factors in triple-negative breast cancer by targeting miR-152-3p: In vivo and in vitro studies
- An evaluation in vitro of the efficacy of nutlin-3 and topotecan in combination with 177Lu-DOTATATE for the treatment of neuroblastoma
- Enhancement of the efficacy of cancer chemotherapy by the pineal hormone melatonin and its relation with the psychospiritual status of cancer patients
- Retinoic acid nuclear receptor alpha(RAR alpha) plays a major role in retinoid-mediated inhibition of growth in human breast carcinoma cells
- Preclinical studies on the anticancer activity of the somatostatin analogue octreotide (SMS 201-995)
- The effects of oral melatonin on skin color and on the release of pituitary hormones
- Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin
- Vitamin D and DDX4 regulate the proliferation and invasion of ovarian cancer cells
- Growth hormone-releasing hormone receptor antagonists modify molecular machinery in the progression of prostate cancer
- Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis
- Somatostatin Octapeptide Inhibits Cell Invasion and Metastasis in Hepatocellular Carcinoma Through PEBP1
- Growth hormone-releasing hormone (GHRH) promotes metastatic phenotypes through EGFR/HER2 transactivation in prostate cancer cells
- Enhancement of the efficacy of weekly low-dose taxotere by the long acting anti-prolactinemic drug cabergoline in pretreated metastatic breast cancer
- Molecular pharmacology of somatostatin-receptor subtypes
- Expression of Somatostatin Type-2 and -4 Receptor and Correlation with Histological Type in Breast Cancer
Most Read
- All-trans-retinoic acid and cancer
- The Di Bella Method (DBM)
- Biography
- About melatonin - 1996
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Bibliography
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Somatostatin in oncology, the overlooked evidences
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Vademecum
- Frequently Asked Questions
- How effective is chemo therapy?
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
- Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathways